KMI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Kinder Morgan Inc (KMI) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, consistent dividend growth, and positive long-term growth catalysts make it an attractive option for passive income and stable returns.
The stock is showing bullish momentum with moving averages in an upward trend (SMA_5 > SMA_20 > SMA_200). The MACD histogram is positive at 0.0358, indicating bullish sentiment, though it is contracting. RSI is at 88.061, signaling overbought conditions, but this is typical in strong uptrends. The stock is trading near its resistance level of R1: 33.079, with further resistance at R2: 33.51.
Hedge funds are significantly increasing their positions in KMI, with a 254.35% increase in buying activity.
Kinder Morgan has $10 billion in growth capital projects expected to complete by 2030, supporting its 3.6% dividend yield and future cash flow growth.
The company delivered strong Q4 financial results, with revenue up 13.07% YoY, net income up 49.47% YoY, and EPS up 50.00% YoY.
Analysts have raised price targets, with Barclays increasing it to $34 and TD Cowen to $35, reflecting confidence in the company's growth potential.
RSI indicates overbought conditions, suggesting the stock may be due for a short-term pullback.
Freedom Capital views the stock as trading near fair value, with limited short-term upside potential.
The stock's historical trend suggests a 60% chance of a -2.8% decline over the next month, which may concern short-term traders.
In Q4 2025, Kinder Morgan reported strong financial performance: Revenue increased by 13.07% YoY to $4.508 billion, net income surged by 49.47% YoY to $991 million, EPS grew by 50% YoY to $0.45, and gross margin improved by 5.27% YoY to 36.73%. These results highlight robust growth and operational efficiency.
Analysts are generally positive on KMI, with multiple firms raising price targets recently. Barclays raised its target to $34 and maintains an Overweight rating, while TD Cowen increased its target to $35 with a Buy rating. However, some analysts, such as Freedom Capital, believe the stock is trading near fair value with limited short-term upside.
